Studies related to Acne and Vitamin B3 (Niacin)

1-Methylnicotinamide: A Potent Anti-inflammatory Agent Of Vitamin Origin

Effect Decrease
Trial Design Double blind
Trial Length 2-4 Weeks
Number of Subjects 175
Sex n/a
Notes for this study:
Twice daily topical application of a cream containing the nicotinamide metabolite known as 1-methylnicotinamide (at 0.1-0.5%) in subjects with either acne vulgaris or eczema over the course of 1-3 weeks noted significantly more beneficial responses when compared to placebo cream.

Subjects who had visible burns appeared to see benefits with MNA relative to placebo.

Full details on all 3 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.